ArticleThe Lancet. Global health2021

The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis.

Andrew N Phillips et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.